On Tuesday, October 27, Express Scripts will announce its third-quarter results after the market closes. While shares have pulled back about 7% since it last reported results, the healthcare ...

Express Scripts Holding Co. defeated a bid by retail drugstores to suspend its $29.1 billion purchase of Medco Health Solutions Inc. while a lawsuit challenging the takeover is pending. Express ...

In Express Scripts’ report Monday and the conference call Tuesday morning, look for guidance about whether company management has any better expectations for the coming year. If the pessimism ...

In Express Scripts’ report, watch for how much of its sales come from generic drugs, which are more profitable for the company. As more newly off-patent drugs produce new generics, Express Scripts ...

Express Scripts Holding, a pharmacy benefit manager that negotiates drug prices for many health plans, will launch a formulary with lower list price drugs in an effort to reduce reliance on rebates ...

NEW YORK (AP) -- Shares of Express Scripts Holding Co. fell 12 percent on Tuesday after the pharmacy benefits manager said Wall Street's expectations for its 2013 earnings may be too optimistic. THE ...

Kathleen Mazzarella, chairman, president and CEO of Graybar. Express Scripts Holding Co. has elected Kathleen Mazzarella, chairman, president and CEO of Graybar Electric Co. Inc., to its board.

Total spending on health care in the United States is expected to climb from $3 trillion to over $4 trillion annually by the end of the decade, and while that may mean sales growth for a lot of health ...

Improved operating performance, the increased usage of generic drugs and the realization of synergies related to its acquisition of a key rival helped Express Scripts Holding Co. raise profits in the ...

Express Scripts Holding Company, the nation’s leading pharmacy benefit manager, is expected to build a 220,000-square-foot building on its existing campus in St. Louis County and add up to 1,500 jobs ...

(Reuters) - Express Scripts Holding Co, the largest U.S. pharmacy benefit manager, on Friday said it will remove 25 products from its 2015 list of preferred drugs, including anemia treatments Epogen ...